Related Experiment Video
Updated: Jul 24, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Intravenous co-infusion of adenosine and norepinephrine preconditions the heart without adverse hemodynamic effects
M V Cohen1, J D Thornton, C S Thornton
1Department of Medicine, University of South Alabama College of Medicine, Mobile 36688, USA.
Insights
A novel combination of adenosine and norepinephrine effectively preconditioned rabbit hearts against infarction during ischemia. This parenteral method offers a safe and feasible approach for cardiac protection during limited coronary artery bypass grafting procedures.
Area of Science:
- Cardiovascular Science
- Pharmacology
Background:
- Myocardial infarction during coronary artery bypass grafting (CABG) necessitates protective strategies.
- Current preconditioning agents like adenosine and norepinephrine have limitations due to adverse hemodynamic effects.
Purpose of the Study:
- To evaluate the cardioprotective potential of a combined adenosine-norepinephrine infusion for myocardial preconditioning.
- To determine if a mixture of adenosine and norepinephrine can mitigate adverse hemodynamic effects while providing cardiac protection.
Main Methods:
- Rabbit hearts underwent 30-minute coronary artery occlusion to induce infarction.
- Cardioprotection was assessed by measuring infarct size after reperfusion.
- The study compared intravenous co-infusion of adenosine and norepinephrine prior to ischemia with adenosine bolus injections.
Main Results:
- Adenosine-norepinephrine co-infusion significantly reduced infarct size to 9% +/- 2% compared to 40% +/- 4% in controls (p = 0.0001).
- This protective effect was maintained up to a 60-minute interval before ischemia but not at 120 minutes.
- Adenosine bolus injections caused hypotension and minimal infarct size reduction.
Conclusions:
- Adenosine-norepinephrine co-infusion is a safe and feasible parenteral method for cardiac preconditioning.
- This combination therapy shows promise for protecting the heart during limited-access CABG.
Objective:
A simple intervention is needed that could protect the heart against infarction during limited-access coronary artery bypass grafting. Adenosine and norepinephrine can precondition the heart with resulting protection, but adverse hemodynamic effects prevent clinical application. Because heart rate, blood pressure, and contractility effects of these two drugs are diametrically opposite, a mixture might be beneficial.
Methods:
A superficial branch of the left coronary artery of rabbits was surrounded with a suture. Infarction was produced in all hearts by a 30-minute coronary artery occlusion. Infarct size after reperfusion was measured and is presented as a percentage of the risk zone. The effect of 5-minute intravenous co-infusion of adenosine (20 mg/kg) and norepinephrine (0.1 mg/kg) 15 minutes before ischemia was examined. In addition, the protective effect of three sequential intravenous bolus injections of adenosine at either 0.2 or 0.4 mg/kg was evaluated.
Results:
Thirty minutes of regional ischemia caused infarction of 40% +/- 4% of the risk zone. The combination of adenosine and norepinephrine caused no change in blood pressure but rather protected the heart, with infarction of only 9% +/- 2% of the risk zone (p = 0.0001 vs control). Adenosine-norepinephrine co-infusion still protected the heart when the interval between infusion and ischemia was extended to 60 minutes, but it did not protect with a 120-minute interval. Intravenous bolus injections of adenosine resulted in cardiac slowing and marked hypotension. Boluses of 0.2 mg/kg resulted in a minimal, but significant, reduction in infarct size, whereas the higher dose provided no protection.
Conclusion:
Adenosine-norepinephrine co-infusion provides a feasible and safe parenteral method for preconditioning the heart.
Related Concept Videos
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Heart Failure Drugs: Inotropic Agents
Imaging Studies for Cardiovascular System V: CT
Cardiac Catheterization I: Pre-Procedure Overview
Cardiac Catheterization IV: Nursing Management
Cardiopulmonary Resuscitation IV: Pharmacological Management

